帕瑞昔布钠用于鼻内镜手术术后镇痛疗效评价

帕瑞昔布钠用于鼻内镜手术术后镇痛疗效评价
周冬青;周期;陈立;王丽云;谢海
【期刊名称】《海南医学》
【年(卷),期】2012(023)011
【摘要】目的观察帕瑞昔布钠用于鼻内镜手术术后镇痛的镇痛效果和安全性.方法选择ASA Ⅰ～Ⅱ鼻内镜手术患者90例,随机分为帕瑞昔布钠组(A组)术毕前15 min静注帕瑞昔布钠40 mg、曲马多组(B组)术毕前15 min静注曲马多40 mg
和生理盐水组(C组)术毕前15分钟静注等量生理盐水,每组各30例.监测血流动力学,比较术毕即刻(T0)、拔管前5 min (T1)、拔管即刻(T2)、拔管后5 min(T3)血压、心率、SpO2变化.比较术后2h、4h、8h、12h和24h VAS和BCS评分及不良反应.结果 A组T1、T3各时点SP、DP、MAP、HR低于B组(P＜0.05),T1、T3各
时点SP、DP、MAP、HR C组均高于A组和B组(P＜0.05),与T0时点比较,B组
和C组T1、T2、T3时点SP、DP、MAP、HR明显升高(P＜0.05). T3时点
SpO2 C组均低于A、B两组,P＜0.05,但其值均在97％以上,无临床意义.VAS评分术后2h、4h、8h、12h各时点A组低于B组(P＜0.05),B组低于C组P＜
0.05);BCS评分:术后2h、4h、8h各时点A组高于B组(P＜0.05),B组高于C组(P ＜0.05)；不良反应比较:B组恶心、呕吐率高于A、C两组(P＜0.05).结论帕瑞昔
布钠用于鼻内镜术后镇痛效果确切,不良反应少.%Objective To study the efficacy and safety of parecoxib sodium for postoperative analgesia of nasal endoscopic surgery. Methods Ninety ASA I ~ II patients undergoing nasal endoscopic surgery were randomly di-vided into three groups, each with 30 cases. Parecoxib sodium group (group A) were injected
intravenously with 40 mg parecoxib sodium 15 minutes before operation; Teamadol group (group B) were injected intravenously with 40 mg Teamadol hydrochloride at the same time; saline group (group C) were injected intravenously with equivalent saline at the same time. Hemodynamics were observed, and the blood pressure, heart rate and pulse oxygen saturation were compared between the there groups at the end of operation (T0), 5 minutes before extubation (T1), at the extubation (T2), and 5 minutes after extubation (T,). The postoperative analgesic effects were evaluated with VAS and BCS scores as well as adverse effects at 2 h, 4 h, 8 h, 12 h, and 24 h after surgery. Results At T, and T,, SP, DP, MAP, HR were significantly lower in group A than group B (P<0.05), and those in group B was significantly lower than those in group C (P<0.05). SD, DP, MAP, HR in group B and group C were increased significantly at the
T1 ,T2 ,T3 compared with those at TO (P<0.05). The levels of SpO2 was lower in group C than of group A and group B at T3 (P<0.05), but the levels were all more than 97%, with no clinical significance. VAS scores were significantly lower in group A than group B at 2 h, 4 h, 8 h, and 12 h after surgery (P0.05), and the scores were significantly lower in group B than group C (P<0.05). BCS scores were significantly higher in group A than group B at 2 h, 4 h, and 8 h after surgery (P<0.05), and the scores were significantly higher in group B than group C (P<0.05). The incidence of adverse effects were significantly higher in Group B than group A and group C (P<0.05). Conclusion Parecoxib sodium is quite effective for
postoperative analgesia of nasal endoscopic surgery, with less adverse effects.
【总页数】3页(P12-14)
【作者】周冬青;周期;陈立;王丽云;谢海
【作者单位】海南医学院附属医院麻醉科,海南海口570102;海南医学院附属医院麻醉科,海南海口570102;海南医学院附属医院麻醉科,海南海口570102;海南医学院附属医院麻醉科,海南海口570102;海南医学院附属医院麻醉科,海南海口570102
【正文语种】中文
【中图分类】R765.04+1
【相关文献】
1.帕瑞昔布钠联合曲马多用于鼻内镜手术后镇痛 [J], 丁登峰;李亚丽;陶明哲
2.帕瑞昔布钠用于鼻内镜手术后镇痛效果的临床观察 [J], 徐枫;杨承祥;梁桦
3.帕瑞昔布钠应用于鼻内镜手术的术后镇痛效应观察 [J], 樊晋荣;王丽娟
4.帕瑞昔布钠用于鼻内镜手术的术后镇痛作用 [J], 梅喜;黄东
5.不同时点应用帕瑞昔布钠对鼻内镜手术患者术后镇痛及舒适度的影响 [J], 魏红琴;汪俊;邵雪泉;吴秋美;徐志毅;徐蓝艳
因版权原因，仅展示原文概要，查看原文内容请购买。